Venture Life Group PLC (VLG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Venture Life Group PLC (VLG) has a cash flow conversion efficiency ratio of -0.012x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-955.00K ≈ $-116.20 USD) by net assets (GBX81.42 Million ≈ $9.91K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Venture Life Group PLC worth for the company's overall valuation and market capitalisation.
Venture Life Group PLC - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Venture Life Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Venture Life Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Venture Life Group PLC ranked by their cash flow conversion efficiency. Explore how high is Venture Life Group PLC's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Biora Therapeutics, Inc.
NASDAQ:BIORQ
|
0.082x |
|
Biora Therapeutics Inc
NASDAQ:BIOR
|
0.082x |
|
WELLFIELD TECHNOLOG. INC.
F:K8D
|
0.028x |
|
Rimo International Lestari Tbk PT
JK:RIMO
|
-0.030x |
|
Wingara AG Ltd
AU:WNR
|
-1.348x |
|
Aranjin Resources Ltd
V:ARJN
|
-0.499x |
|
New Energy Metals Corp
V:ENRG
|
0.045x |
|
Prominence Energy Limited
F:RSX
|
-0.150x |
Annual Cash Flow Conversion Efficiency for Venture Life Group PLC (2010–2025)
The table below shows the annual cash flow conversion efficiency of Venture Life Group PLC from 2010 to 2025. View today's stock price for Venture Life Group PLC for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX81.42 Million ≈ $9.91K |
GBX-264.00K ≈ $-32.12 |
-0.003x | -102.93% |
| 2024-12-31 | GBX75.41 Million ≈ $9.18K |
GBX8.35 Million ≈ $1.02K |
0.111x | +2.73% |
| 2023-12-31 | GBX76.25 Million ≈ $9.28K |
GBX8.22 Million ≈ $1.00K |
0.108x | +46.53% |
| 2022-12-31 | GBX75.66 Million ≈ $9.21K |
GBX5.57 Million ≈ $677.22 |
0.074x | +795.58% |
| 2021-12-31 | GBX73.16 Million ≈ $8.90K |
GBX601.00K ≈ $73.12 |
0.008x | -78.11% |
| 2020-12-31 | GBX72.11 Million ≈ $8.77K |
GBX2.71 Million ≈ $329.24 |
0.038x | -49.55% |
| 2019-12-31 | GBX32.82 Million ≈ $3.99K |
GBX2.44 Million ≈ $297.00 |
0.074x | +902.63% |
| 2018-12-31 | GBX32.08 Million ≈ $3.90K |
GBX238.00K ≈ $28.96 |
0.007x | +225.28% |
| 2017-12-31 | GBX14.19 Million ≈ $1.73K |
GBX-84.00K ≈ $-10.22 |
-0.006x | +81.40% |
| 2016-12-31 | GBX14.36 Million ≈ $1.75K |
GBX-457.00K ≈ $-55.60 |
-0.032x | +60.39% |
| 2015-12-31 | GBX13.80 Million ≈ $1.68K |
GBX-1.11 Million ≈ $-134.93 |
-0.080x | +43.47% |
| 2014-12-31 | GBX15.65 Million ≈ $1.90K |
GBX-2.22 Million ≈ $-270.60 |
-0.142x | +92.35% |
| 2013-12-31 | GBX557.00K ≈ $67.77 |
GBX-1.03 Million ≈ $-125.93 |
-1.858x | +54.27% |
| 2012-12-31 | GBX127.00K ≈ $15.45 |
GBX-516.00K ≈ $-62.78 |
-4.063x | -164.65% |
| 2011-12-31 | GBX312.00K ≈ $37.96 |
GBX-479.00K ≈ $-58.28 |
-1.535x | -30.19% |
| 2010-12-31 | GBX212.00K ≈ $25.79 |
GBX-250.00K ≈ $-30.42 |
-1.179x | -- |
About Venture Life Group PLC
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermat… Read more